-
6 days ago | 
celebritynetworth.com | Alex Chan
What is Julie Delpy's Net Worth? Julie Delpy is a French actress, filmmaker, and musician who has a net worth of $8 million. Julie Delpy is known for her performances in such films as "Beatrice," "Voyager," "Three Colors: White," "An American Werewolf in Paris," and the "Before" trilogy. She also co-wrote the latter two films in the "Before" trilogy, earning Academy Award nominations for Best Adapted Screenplay for both.
-
6 days ago | 
celebritynetworth.com | Alex Chan
What is Donnie Yen's Net Worth? Donnie Yen is a Chinese actor, martial artist, director, and choreographer who has a net worth of $50 million. Donnie Yen has revolutionized martial arts cinema through his innovative fight choreography and exceptional physical abilities. Rising to prominence in the 1990s, Yen achieved international fame through his portrayal of Wing Chun grandmaster Ip Man in the acclaimed film series of the same name.
-
1 week ago | 
celebritynetworth.com | Alex Chan
What is Andrew Lawrence's net worth? Andrew Lawrence is an American actor who has a net worth of $1 million. Andrew Lawrence is an American actor, filmmaker, podcaster, and singer who rose to prominence as a child star in the 1990s. Beginning his entertainment career at just three years old, Lawrence quickly established himself in Hollywood alongside his famous brothers, Joey and Matthew Lawrence.
-
1 week ago | 
2minutemedicine.com | Simon Pan |Alex Chan
1. While not statistically significant, the use of sotorasib plus panitumumab may have a 30% relative risk reduction in the risk of death compared to the investigator’s choice of chemotherapy in the management of Kirsten rat sarcoma viral oncogene homologue (KRAS) glycine-to-cysteine mutation at codon 12 (KRAS G12C) colorectal cancer.
-
1 week ago | 
celebritynetworth.com | Alex Chan
What is Barbara Carrera's Net Worth? Barbara Carrera is a former actress and model who has a net worth of $10 million.
-
1 week ago | 
celebritynetworth.com | Alex Chan
What is Bruce Karsh's Net Worth? Bruce Karsh is an American lawyer and investor who has a net worth of $2.4 billion. Bruce Karsh and Howard Marks co-founded the financial behemoth Oaktree Capital Management, one of the world's leading alternative investment firms specializing in distressed debt. With a reputation for navigating complex financial landscapes, Karsh has quietly become one of the most influential figures in modern finance, helping manage more than $170 billion in assets at Oaktree.
-
1 week ago | 
celebritynetworth.com | Alex Chan
What is Jarvis Cocker's Net Worth? Jarvis Cocker is an English musician who has a net worth of $5 million. Jarvis Cocker emerged as one of British music's most distinctive and eloquent voices during the Britpop era of the 1990s. As the frontman and lyricist of Pulp, Cocker crafted literate, sardonic songs of observation that chronicled working-class life, sexual longing, and social commentary with uncommon wit and insight.
-
1 week ago | 
celebritynetworth.com | Alex Chan
What is Howard Marks's Net Worth? Howard Marks is an American investor who has a net worth of $2.2 billion. Howard Marks and Bruce Karsh co-founded the global asset management firm Oaktree Capital Management, the world's largest investor in distressed securities. Previously, he worked at TCW Group and Citicorp. Marks shares his investment strategies through essays he posts on the Oaktree website, as well as through some published books.
-
1 week ago | 
celebritynetworth.com | Alex Chan
What is Kari Ann Peniche's Net Worth? Kari Ann Peniche is a former beauty queen who has a net worth of $50 thousand. Kari Ann Peniche's career has traversed modeling, pageantry, television, and music, marked by both achievement and controversy. Rising to prominence after winning the Miss United States Teen pageant in 2002, Peniche later made headlines when she was stripped of her Miss Oregon Teen USA title after posing for Playboy magazine in 2004.
-
1 week ago | 
2minutemedicine.com | Paary Balakumar |Alex Chan
1. In high-risk patients, point-of-care capillary HbA1c was superior to venous HbA1c as uptake was double, leading to faster results, fewer repeat visits, and identified more undiagnosed Type 2 Diabetes Mellitus. Evidence Rating Level: 1 (Excellent)This cluster randomized controlled trial evaluated point-of-care capillary HbA1c (POC-cHbA1c) versus standard venous HbA1c (vHbA1c) for type 2 diabetes (T2D) screening across 8 Hong Kong primary care clinics.
